Search

everythinglearnresearchcommunity

for

Search:↓

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Women may need different blood pressure guidelines than men for heart disease prevention.

The document concludes that managing hirsutism in PCOS involves long-term treatment guided by severity, using oral contraceptives and possibly antiandrogens, with attention to individual patient needs.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Many recovered COVID-19 patients in Saudi Arabia still experience symptoms like fatigue and anxiety, especially older adults and those with other health issues.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

A new skin treatment using a patient's own cells healed chronic wounds effectively and was preferred over traditional grafts.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

People with alopecia areata are more likely to have other immune-related conditions.

Eating disorders can cause skin problems that need treating the underlying condition for better health.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

Vitiligo causes significant emotional stress in Africa, the Middle East, and Latin America, with limited treatment options available.

BMI is not a significant predictor of complications after gender-affirming penile inversion vaginoplasty.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Antimalarial drugs, especially chloroquine, can effectively treat granuloma annulare.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Pegvaliase effectively reduces blood phenylalanine levels in most PKU patients, but requires personalized plans and good communication to manage side effects.

Many hospitalized COVID-19 patients still have symptoms like fatigue and hair loss up to a year later, especially older, lower-income individuals with other health issues.

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Various treatments exist for hair loss, but more research is needed for better options.

Early detection and treatment of urinary symptoms can help maintain functional ability in older adults.